官方服务：
资源简介：
RNA-seq of the human melanoma cell-line A375P treated with the BRAF inhibitor PLX4720 and a DMSO control
应用场景：
创建时间：
2025-01-23
相关数据集
Hs 294T Cells Treated with Elesclomol Alone or in Combination with NAC Compared to DMSO Treated
We used microarrays to detail gene expression changes in Hs 294T human melanoma cells after treatment with elesclomol alone, or in combination with NAC, to aide in identifing the mechnism of action of
NIAID Data Ecosystem60
An in vivo avian model of human melanoma to perform rapid and robust preclinical studies
Metastatic melanoma patients carrying a BRAFV600 mutation can be treated with a combination of BRAF and MEK inhibitors (BRAFi/MEKi), but innate and acquired resistance invariably occurs. Predicting pa
NIAID Data Ecosystem40
Additional file 15 of Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironment
Supplemental Material 15. Supplemental Table 2.
NIAID Data Ecosystem20
The PPAR agonist Rosiglitazone induces paracrine signaling in melanoma cells that activate stromal cells and enhances tumor growth.. The PPAR agonist Rosiglitazone induces paracrine signaling in melanoma cells that activate stromal cells and enhances tumor growth.
Besides improving insulin sensitivity in type 2 diabetes, the thiazolidinedione family of compounds and the pharmacologic activation of their best characterized target PPARg has been proposed as a the
NIAID Data Ecosystem50
Effect of alisertib and navitoclax on gene expression in B16 melanoma tumors. Effect of alisertib and navitoclax on gene expression in B16 melanoma tumors
To investigate how tumor cells respond to alisertib and navitoclax single agents and combonation therapy in vivo, mice with melanoma were treated with these agents or vehicle-contol. RNAseq was used t
NIAID Data Ecosystem30
